checkAd

     161  0 Kommentare Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year

    Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year

    First year as fully transformed company has ended with moderate success. PRFoods regained profitability despite significantly lower revenues. Q4 revenues were less by 25% and full year by 53%, since we no longer have our Swedish or Finnish operations. Center of our operations is now UK and Estonian fish processing and farming.

    We ended full year with 19,6 million Euro sales compared to 42,1 million last year, but more importantly, our previous year -1,6 million EBITDA loss was replaced with 0,3 million Euro profit, 118,75% improvement.

    PRFoods first net profit in many years was 350,000 Euros (last year - 8,2 million loss). Two out of three of our operations: fish farming, Estonian processing and UK and fish farming were profitable. Estonian processing unit posted loss.

    Our result could have been even better, but our exclusive seller in Finland decided to end the co-operation in May. While in short term it causes pain, in long term this will benefit us handsomely, since from 2024 we no longer are prohibited by non-competition in Finland, can sell directly to retailers and hope to regain several million Euros in sales already in 2024. High food prices in Estonia and governments plan to raise VAT will dampen demand in Estonia, rise inflation and also affect the competitiveness of Estonian industries. It is a challenge, but with new management in helm at Estonia, I am fully confident that Estonian processing operations will also be profitable next year.

    I am extremely pleased that our UK business reached over 1 million Euros Ebitda again, after COVID crisis and now inflationary pressures. John Ross Jr continues to be best Scottish smoked salmon brand and the management has excelled again.

    I am also very pleased to announce that our new fish farming licence application in Estonia has been approved and we expect to get the water usage permit in September 2023, meaning we can scale up our fish farming production already from 2024.

    Q1 of current year is tough still for Estonia, UK forecast is promising and we expect historically best result from fish farming unit. Cashflow management remains a challenge. Unfortunately we were forced to sell off our profitable Swedish unit to fully repay group level bank loan, this unit could have helped us to regain profitability much faster at much higher level. Leverage is still too high for regained profitability and additional support from shareholders is needed.

    We live in interesting times, and one challenge is replaced by another for most of the industries that are not protected or subsidised by government.

    KEY RATIOS

    INCOME STATEMENT

    mln EUR
    (unless indicated otherwise)
    4Q 2022/2023 12 mos 2021/2022 4Q 2021/2022 12 mos 2020/2021
    Sales 4,0 19,6 5,3 42,1
    Gross profit 0,4 3,6 0,5 3,1
    EBITDA from operations 0,1

    0,3
    0,4 -1,2
    EBITDA 0,1 0,3 -0,3 -1,6
    EBIT -0,3 -1,0 -1,1 -4,2
    EBT -0,5 0,4 -1,5 -8,2
    Net profit (loss) -0,5 0,35 -1,5 -8,2
    Gross margin 9,9% 18,3% 10,0% 7,4%
    Operational EBITDA margin 2,3% 1,6% 7,6% -2,8%
    EBITDA margin 2,3% 1,6% -6,3% -3,7%
    EBIT margin -7,6% -5,0% -21,3% -9,9%
    EBT margin -12,7% 2,2% -28,7% -19,5%
    Net margin -12,3% 1,8% -29,0% -19,4%
    Operating expense ratio -21,3% -24,0% -25,8% -17,1%

     

     

    BALANCE SHEET

    mln EUR

    unless indicated otherwise
    30.06.2023 30.06.2022 30.06.2021
    Net debt 16,9 24,7 22,4
    Equity 7,5 8,1 15,8
    Working capital 0,3 -3,2 -3,2
    Assets 29,9 38,9 55,6
    Liquidity ratio 1,1x 0,7x 0,8x
    Equity ratio 25,1% 20,7% 28,4%
    Gearing ratio 69,2% 75,4% 58,7%
    Debt to total assets 0,7x 0,8x 0,7x
    Net debt to operating EBITDA 54,9x -14,5x -17,9x
    ROE 4,4% -68,5% -29,0%
    ROA 1,0% -17,3% -9,2%

     

     

    Consolidated Statement of Financial Position

    EUR '000 30.06.2023 30.06.2022
    ASSETS    
    Cash and cash equivalents 394 110
    Receivables and prepayments 2 168 2 567
    Inventories 1 861 2 196
    Biological assets 772 3 003
    Total current assets 5 195 7 876
         
    Deferred tax assets - 93
    Long-term financial investments 381 229
    Tangible assets 6 563 8 882
    Intangible assets 17 718 21 837
    Total non-current assets 24 662 31 041
    TOTAL ASSETS 29 857 38 917
         
    EQUITY AND LIABILITIES    
    Interest-bearing liabilities 1 793 7 094
    Payables and prepayments 3 127 3 978
    Total current liabilities 4 919 11 073
         
    Interest-bearing liabilities 15 461 17 725
    Payables and prepayments - 204
    Deferred tax liabilities 1 664 1 599
    Government grants 318 265
    Total non-current liabilities 17 442 19 792
    TOTAL LIABILITIES 22 361 30 865
         
    Share capital 7 737 7 737
    Share premium 14 007 14 007
    Treasury shares - 390 - 390
    Statutory capital reserve 51 51
    Currency translation differences 549 839
    Retained profit (loss) -14 719 - 14 391
    Equity attributable to parent 7 236 7 853
    Non-controlling interest 259 199
    TOTAL EQUITY 7 495 8 052
    TOTAL EQUITY AND LIABILITIES 29 857 38 917

     

     

    Consolidated Statement of Profit or Loss And Other Comprehensive Income

    EUR '000 4Q

    2022/2023
    4Q

    2021/2022
    12m

    2022/2023
    12m

    2021/2022
    Revenue 3 993 5 250 19 578 42 128
    Cost of goods sold -3 599 -4 723 -16 003 -38 993
    Gross profit 394 528 3 575 3 136
             
    Operating expenses -851 -1 354 -4 706 -7 207
    Selling and distribution expenses -755 -630 -2 691 -4 843
    Administrative expenses -96 -724 -2 015 -2 364
    Other income / expense 152 443 150 307
    Fair value adjustment on biological assets 0 -734 0 -420
    Operating profit (loss) -305 -1 117 -982 -4 184
    Financial income / expenses -203 -388 1 416 4 039
    Profit (Loss) before tax -508 -1 505 434 -8 223
    Income tax 19 -20 87 63
    Net profit (loss) for the period -489 -1 525 347 -8 160
             
    Net profit (loss) attributable to:        
    Owners of the Parent Company -503 -1 502 319 -8 143
    Non-controlling interests 13 -23 28 -17
    Total net profit (loss) for the period -489 -1 525 347 -8 160
             
    Other comprehensive income (loss) that may subsequently be classified to profit or loss:        
    Foreign currency translation differences 288 148 -290 280
    Total comprehensive income

    (expense)
    -201 -1 377 57 -7 880
             
    Total comprehensive income (expense) attributable to:        
    Owners of the Parent Company -215 -1 354 29 -7 863
    Non-controlling interests 13 -23 28 -17
    Total comprehensive income

    (expense) for the period
    -201 -1 377 57 -7 880
             
    Profit (Loss) per share (EUR) -0,01 -0,04 0,01 -0,21
             
    Diluted profit (loss) per share (EUR) -0,01 -0,03 0,01 -0,21

     

     

    Indrek Kasela

    AS PRFoods

    Member of the Management Board

    Phone:+372 452 1470

    investor@prfoods.ee

    www.prfoods.ee

    Attachment





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year First year as fully transformed company has ended with moderate success. PRFoods regained profitability despite significantly lower …